Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentation

doi:10.12998/wjcc.v4.i12.390

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12632)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-2) series.

Item

Count

PDF

436

WORD

358

HTML

8488

Figures (1-10)

778

Tables (1-2)

219

Sum=10279

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1016

Download

1337

Sum=2353

Dec 16, 2016 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Dec 16, 2016; 4(12): 390-400
Published online Dec 16, 2016. doi: 10.12998/wjcc.v4.i12.390

Full Size Figure Download Figure

Figure 10 The paclitaxel-associated interface dermatitis lesion on the right ankle progressed in severity and distribution. A similar lesion also developed on the left ankle.

Citation: Cohen PR. Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentation. World J Clin Cases 2016; 4(12): 390-400
URL: https://www.wjgnet.com/2307-8960/full/v4/i12/390.htm
DOI: https://dx.doi.org/10.12998/wjcc.v4.i12.390